Kuwait hails traditional Chinese medication for treating coronavirus


(MENAFN) Kuwait has imposed a number of procedures to control the spread of COVID-19 since it's seeing a rise in number of coronavirus infections as the pandemic carries on raging worldwide.

The traditional Chinese medication Lianhua Qingwen is an effective drug as a cure for COVID-19 symptoms, stated Fahd Ghazi Al-Mutairi, chairman of Kuwaiti firm Sour Al-Sain on behalf of the Chinese drug maker Yiling Pharmaceutical on Kuwait's market.

Al-Mutairi added that Lianhua Qingwen, a licensed traditional Chinese medication that is broadly utilized in China to cure patients suffering from the COVID-19, has been approved by the Pharmaceutical and Herbal Medicine Registration and Control Administration of Kuwait for the treatment of symptoms due to coronavirus.

The licensed drug by the Kuwaiti side has demonstrated its efficiency in treating the COVID-19, said Al-Mutairi while addressing Xinhua in a latest interview.

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.